Should I microdose with ibogaine, LSD or psilocybin?
Microdosing is the latest mental health craze, with millions of people around the world now taking tiny amounts of psychoactive substances on a regular basis in order to treat depression, addiction and anxiety, or to increase their creativity, productivity and wellbeing.
When it comes to microdosing, LSD and psilocybin are the two most popular substances worldwide. Both act on the brain’s serotonin receptors in order to help regulate mood, while also generating an increase in global connectivity throughout the brain, leading to more flexible and creative thinking. As a consequence, both have been shown to help treat depression and addiction.
Like LSD and psilocybin, ibogaine helps to regulate serotonin, thereby generating enhanced mood. Unlike other substances, however, ibogaine accumulates in the liver when taken regularly, becoming stored as noribogaine, which continues to make more serotonin available to brain cells for several weeks.
Ibogaine also interacts with a wider range of brain receptors than both LSD and psilocybin. For example, its ability to bind to opioid receptors makes it ideal for treating addiction, and regular microdoses are an effective way to lessen cravings and withdrawal symptoms. On top of this, vidence is beginning to suggest that microdosing with ibogaine can also help to treat Parkinson’s disease, possibly because of the way in which it stimulates the release of growth factors in the brain.
However, because of its wider-ranging activity, ibogaine can also produce certain side-effects that are not normally associated with LSD or psilocybin. These may include restlessness, irritability, or trouble sleeping.
For more information about microdosing with ibogaine, visit www.ibogainemicrodosing.org